Akers Biosciences, Inc. Waiver Agreements
1 Contracts & Agreements
- Form of Omnibus Waiver and Amendment, dated April 5, 2024, by and between MyMD Pharmaceuticals, Inc. and the investors party thereto (Filed With SEC on April 8, 2024)
